Data Availability
The data is available at http://adni.loni.usc.edu/data-samples/access-data. Data collection and sharing for this project was provided by the Alzheimer”s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer”s Association Alzheimer”s Drug Discovery Foundation Araclon Biotech BioClinica, Inc. Biogen Bristol-Myers Squibb Company CereSpir, Inc. Cogstate Eisai Inc. Elan Pharmaceuticals, Inc. Eli Lilly and Company EuroImmun F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc. Fujirebio GE Healthcare IXICO Ltd. Janssen Alzheimer Immunotherapy Research & Development, LLC. Johnson & Johnson Pharmaceutical Research & Development LLC. Lumosity Lundbeck Merck & Co., Inc. Meso Scale Diagnostics, LLC. NeuroRx Research Neurotrack Technologies Novartis Pharmaceuticals Corporation Pfizer Inc. Piramal Imaging Servier Takeda Pharmaceutical Company and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer”s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
